Share

See Also

Home / ACCCBuzz Blog / Full Story (testing)
1 2 3 4 5 6 7 8 9 10 …

FROM THE ACCCBUZZ BLOG

  • Healthy-lung-and-cancer-lung-150x150
    ACCC Recognizes Lung Cancer Awareness Month
    November 17, 2021
    Lung cancer is the leading cause of cancer death and the second-most common cancer detected in both men and women in the U.S. Lung cancer accounts for nearly 25% of all cancer deaths in this country. According to estimates by the American Cancer Society, 235,760 patients will be diagnosed with lung cancer, and 131,880 patients will die of the disease in 2021.
  • ACCC Supports Legislation to Increase Diversity in Clinical Trials
    November 15, 2021
  • Teamwork Image for Blog
    Oncology Staff Share Staffing, Morale Concerns
    November 10, 2021
    Discussions about staffing shortages, burnout, and heavy workloads have taken center stage during recent meetings with ACCC members. Learn what financial advocates and others are experiencing in their cancer program or practice and leadership are doing or plan to do to rebuild morale and team connections.
  • Precision Medicine 300x200
    Transforming Complex to Clear: New Precision Medicine Tools
    November 09, 2021
    ACCC has launched Transforming Complex to Clear—a precision medicine campaign that has developed a range of tools and resources to help bring clarity to complex patient care decisions. Designed for multidisciplinary cancer teams, learn more about how these resources can enable clinicians to make educated and confident decisions.
  • Biomarker Testing NSLC Roadmap
    ACCC Launches Precision Medicine Campaign
    November 04, 2021
    In launching its new campaign, "Transforming Complex To Clear," ACCC brought together expert panelists to discuss effective practices and offer tips to address current barriers to biomarker testing in the community setting.
  • Care Team Illustration
    New Small-Group CE Opportunities Offer Personalized Virtual Learning
    October 27, 2021
    ACCC is offering two new online continuing education initiatives that leverage small-group learning among clinicians and their peers who have roles in the care and treatment of patients with early-stage NSCLC and patients with advanced HER2+ breast cancer.
  • Care Team Illustration
    New Small-Group CE Opportunities Offer Personalized Virtual Learning
    October 27, 2021
    ACCC is offering two new online continuing education (CE) initiatives that leverage small-group learning among clinicians and their peers who have roles in the care and treatment of patients with early-stage NSCLC and patients with advanced HER2+ breast cancer.
  • Vials in a Box on Pharmacy Counter
    A Toxic Mixture: Burnout in Oncology Pharmacy
    October 26, 2021
  • Jordan Karwedsky Blog
    Preparing for Open Enrollment
    By Jordan Karwedsky
    October 25, 2021
    While we talk to patients about insurance coverage and answer their related questions throughout the year, the health insurance Marketplace and Medicare open enrollment seasons provide the best opportunity to educate patients about their insurance options.
  • breast-cancer-240x160
    The Changing Landscape of Breast Cancer Care
    October 22, 2021
    Due in no small part to global awareness efforts and transformative technological advances in breast cancer treatment, there has been a 40% decline in breast cancer deaths in the past 30 years. Nevertheless, current statistics remain sobering. An estimated 284,200 individuals in the U.S. will be diagnosed with invasive breast cancer in 2021, and approximately 44,130 people will die from the disease, making it the second leading cause of cancer death in women.
  • Health Policy
    Building a Culture of Deliberate Advocacy
    By Matt Devino, MPH
    October 19, 2021
    The key to successful policy and advocacy is twofold: avoid approaching new policies with a preferred conclusion and leverage the strengths of your colleagues.
  • barriers-to-liquid-biopsy-240x160
    Barriers to Liquid Biopsy
    October 14, 2021
    Liquid biopsy, a genetic test that can eliminate some of the most serious potential drawbacks of traditional tissue biopsy, is gaining more traction in cancer care. But there remain significant barriers to its widespread use.
  • Moffit Clinc Team for blog
    Cancer Care from the Comfort of Your Car
    October 07, 2021
    As we struggle to respond to fluctuating COVID-19 infection and vaccination rates, it is important to consider whether some of the initiatives developed in response to the pandemic are worth keeping. One such initiative is Moffitt Cancer Center's Oncology Curbside Clinic.
  • acori-240x160
    ACCC Pursues Health Equity Through ACORI
    October 05, 2021
    In 2021, ACCC launched the ACCC Community Oncology Research Institute (ACORI), which builds on ACCC’s mission to achieve equitable cancer care for all patients by forming key community partnerships. As part of this mission, ACCC hosted the ACORI Call to Action Summit, a two-day virtual event held September 13-14, 2021, to garner participant feedback and guide the future of the institute.
  • Researcher in laboratory
    Health Equity Summit: Conversations on Representation in Clinical Trials
    September 30, 2021
    Although clinical trials have been used for decades to determine the safety and efficacy of drugs and medical devices, the lack of a diverse population in such studies has failed to represent the population suffering the burden of the diseases being studied.
  • fan-playbook-240x160
    ACCC Unveils New Tool for Financial Advocates
    September 28, 2021
    To help cancer programs and practices establish and maintain robust financial navigation programs, ACCC's Financial Advocacy Network recently developed the “Ready, Set, Go! Financial Advocacy Playbook” for all members of the cancer care team—particularly those who provide any level of financial advocacy services.
  • Health Policy
    National Paid Family and Medical Leave May be on the Horizon
    By Matt Devino, MPH
    September 24, 2021
    Despite the havoc it has caused, our continuously unfolding public health emergency has given us hope that some elusive policy initiatives are now not the stretch they once were.
  • Red blood cells travel artery
    ACCC Recognizes Blood Cancer Awareness Month
    September 16, 2021
    With projects that address acute lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL), B-Cell ALL, and hematology disease education, ACCC is developing new resources for cancer programs and practices that focus on multidisciplinary approaches to caring for patients with blood cancer.
  • Despite Setbacks, Biosimilars Market Share Continues to Increase
    By Matt Devino, MPH
    September 10, 2021
    With total spending on U.S. cancer care projected to rise 34 percent from 2015-2030 to $245 billion, biosimilars can play a role in helping reduce those costs. Learn how Biden’s executive order on promoting competition in the American economy will require the FDA's biosimilars approval framework to be clearer and easier to follow.
  • Amanda-Henson-240x160
    Building a Team During the Darkest Days of COVID-19
    By Amanda Henson, MSHA, MBA, FACHE
    August 30, 2021
    Amanda Henson writes a regular blog series for ACCCBuzz about how she created and helps manage a streamlined oncology service line within the Baptist Health System in Kentucky. In this post, Henson talks about Baptist Health's oncology leaders and how they united to problem-solve in the midst of the COVID-19 pandemic.

Related Posts

ACCC on Twitter